Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)

by Wolfgang M. Brueckl, Joachim H. Ficker, Gloria Zeitler
Published 2020-12-01

Transitioning Clinical Data into Patient Care: Recent Real-Life Experiences with Alpha 1

by Jan Stolk, Berend Stoel, David Parr, Joachim H. Ficker, Charlie Strange
Published 2017-10-01

Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study

by Wolfgang M. Brueckl, H. Jost Achenbach, Joachim H. Ficker, Wolfgang Schuette
Published 2018-03-01

Predictors of positive airway pressure therapy termination in the first year: analysis of big data from a German homecare provider

by Holger Woehrle, Michael Arzt, Andrea Graml, Ingo Fietze, Peter Young, Helmut Teschler, Joachim H. Ficker
Published 2018-12-01

Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stag...

by Wolfgang M Brueckl, Martin Reck, Achim Rittmeyer, Jens Kollmeier, Claas Wesseler, Gunther H Wiest, Petros Christopoulos, Amanda Tufman, Petra Hoffknecht, Bernhard Ulm, Fabian Reich, Joachim H Ficker, Eckart Laack
Published 2020-08-01

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies - A Novel Stepwise Approach by Evaluation of Medication.

by Tanja Lucke, Ronald Herrera, Margarethe Wacker, Rolf Holle, Frank Biertz, Dennis Nowak, Rudolf M Huber, Sandra Söhler, Claus Vogelmeier, Joachim H Ficker, Harald Mückter, Rudolf A Jörres, COSYCONET-Consortium
Published 2016-01-01

Afatinib as first-line treatment in patients with -mutated non-small cell lung cancer in routine clinical practice

by Wolfgang M. Brückl, Martin Reck, Frank Griesinger, Harald Schäfer, Cornelius Kortsik, Tobias Gaska, Justyna Rawluk, Stefan Krüger, Konrad Kokowski, Stephan Budweiser, Joachim H. Ficker, Christopher Hoffmann, Andrea Schüler, Eckart Laack
Published 2021-05-01

Diagnosis and management of α1-antitrypsin deficiency in Europe: an expert survey

by Ildikó Horváth, Maria Canotilho, Jan Chlumský, Joanna Chorostowska-Wynimko, Luciano Corda, Eric Derom, Joachim H. Ficker, Meinhard Kneussl, Marc Miravitlles, Maria Sucena, Gabriel Thabut, Alice M. Turner, Emily van ’t Wout, N. Gerard McElvaney
Published 2019-03-01

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

by Jakob M. Riedl, Dominik A. Barth, Wolfgang M. Brueckl, Gloria Zeitler, Vasile Foris, Stefanie Mollnar, Michael Stotz, Christopher H. Rossmann, Angelika Terbuch, Marija Balic, Tobias Niedrist, Thomas Bertsch, Herbert Stoeger, Martin Pichler, Horst Olschewski, Gudrun Absenger, Joachim H. Ficker, Armin Gerger, Florian Posch
Published 2020-08-01

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.

by Kathrin Kahnert, Tanja Lucke, Rudolf M Huber, Jürgen Behr, Frank Biertz, Anja Vogt, Henrik Watz, Peter Alter, Sebastian Fähndrich, Robert Bals, Rolf Holle, Stefan Karrasch, Sandra Söhler, Margarethe Wacker, Joachim H Ficker, Klaus G Parhofer, Claus Vogelmeier, Rudolf A Jörres, COSYCONET consortium
Published 2017-01-01